ARCHIVES

“National Clearinghouse” To Guide Selection, Testing, Evaluating Of Suspected Carcinogens

This article is from The Cancer Letter archive.

Vol. 02 No. 15 | April 9, 1976

Download PDF Visit The Full Archive

Related Articles

Nexavar Phase III Trial Fails To Meet Primary Endpoint

June 29, 2012

Leukemia Biology Study Needed To Improve Results, Pinkel Says In Karnfsky Lecture

April 7, 1978

Drugs and Targets: EU approves Imbruvica in MCL, CLL

October 24, 2014

In Brief: NCI Contract Plans Shaping Up As RFP “Season” Approaches; L-B Profit Told

September 13, 1974

Fisher Seeks Damages Under Privacy Act; NIH Consents To Remove Database Flags

March 10, 1995

NCAB Committee Approves NCI Plans For Organ Systems

February 5, 1988